Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 5:15:1376104.
doi: 10.3389/fneur.2024.1376104. eCollection 2024.

Aging as a target for the prevention and treatment of Alzheimer's disease

Lauren E Yap  1 , James E Hunt  1 , Raymond Scott Turner  1
Affiliations
Review

Aging as a target for the prevention and treatment of Alzheimer's disease

Lauren E Yap et al. Front Neurol. .

Abstract

Alzheimer's disease (AD), the most common etiology of dementia in older adults, is projected to double in prevalence over the next few decades. Current treatments for AD manage symptoms or slow progressive decline, but are accompanied by significant inconvenience, risk, and cost. Thus, a better understanding of the risk factors and pathophysiology of AD is needed to develop novel prevention and treatment strategies. Aging is the most important risk factor for AD. Elucidating molecular mechanisms of aging may suggest novel therapeutic targets. While aging is inevitable, it may be accelerated by caloric excess and slowed by caloric restriction (CR) or intermittent fasting. As such, CR may slow aging and reduce the risk of all diseases of aging, including dementia due to AD. The literature on CR, intermittent fasting, and treatment with polyphenols such as resveratrol-a pharmacologic CR-mimetic-supports this hypothesis based on clinical outcomes as well as biomarkers of aging and AD. More studies exploring the role of CR in regulating aging and AD progression in man are needed to fill gaps in our understanding and develop safer and more effective strategies for the prevention and treatment of AD.

Keywords: Alzheimer’s disease; aging; amyloid; caloric restriction; dementia; intermittent fasting; mild cognitive impairment; resveratrol.

PubMed Disclaimer

Conflict of interest statement

RT reports research funding to Georgetown University from Alector, Biogen, Cognition Therapeutics, Eisai, Janssen, Lilly, Roche/Genentech, Vaccinex, and Vivoryon. RT is a consultant to Re: Cognition Health. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Schematic diagram linking caloric restriction and intermittent fasting with slowing the progression of Alzheimer’s disease by altering mechanisms of aging. AD, Alzheimer’s disease; MCI, mild cognitive impairment.
See this image and copyright information in PMC

References

    1. 2023 Alzheimer's disease facts and figures . Alzheimers Dement. J Alzheimer Rep. 19:1598–5. doi: 10.1002/alz.13016, PMID: - DOI - PubMed
    1. Jack CR, Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. (2018) 14:535–62. doi: 10.1016/j.jalz.2018.02.018, PMID: - DOI - PMC - PubMed
    1. Hampel H, Cummings J, Blennow K, Gao P, Jack CR, Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol. (2021) 17:580–9. doi: 10.1038/s41582-021-00520-w, PMID: - DOI - PubMed
    1. Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. (2022) 7:391. doi: 10.1038/s41392-022-01251-0, PMID: - DOI - PMC - PubMed
    1. Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. (2022) 611:769–79. doi: 10.1038/s41586-022-05439-w, PMID: - DOI - PMC - PubMed